Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Mayrhofer

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
JACC. Cardiooncology|January 13, 2023
Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After ImmunotherapyCharlotte Lee, Zsofia D Drobni, Amna Zafar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2023
Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE CohortBorek Foldyna, Thomas Mayrhofer, Markella V Zanni, et al.
JACC. Cardiovascular Imaging|April 9, 2026
Opportunistic CT-Derived Periaortic Fat Attenuation as a Novel Marker of Mortality in Patients Undergoing TAVRJan M Brendel, Ibrahim Hadzic, Thomas Mayrhofer, et al.
Nature Communications|January 30, 2021
Deep convolutional neural networks to predict cardiovascular risk from computed tomographyRoman Zeleznik, Borek Foldyna, Parastou Eslami, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2022
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)Samuel R Schnittman, Michael T Lu, Thomas Mayrhofer, et al.
American Journal of Preventive Cardiology|May 20, 2024
Lipoprotein subclasses are associated with Hepatic steatosis: insights from the prospective multicenter imaging study for the evaluation of chest pain (PROMISE) clinical trialJulia Karady, Robert W McGarrah, Maggie Nguyen, et al.
JAMA Cardiology|December 11, 2024
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical TrialMárton Kolossváry, Samuel R Schnittman, Markella V Zanni, et al.
JAMA Network Open|June 29, 2021
Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular PreventionUdo Hoffmann, Michael T Lu, Borek Foldyna, et al.
JACC. Cardiovascular Imaging|December 1, 2025
Statin Effects on Pericoronary Adipose Tissue Density in People With HIV: Insights From the REPRIEVE TrialBorek Foldyna, Ibrahim Hadzic, Thomas Mayrhofer, et al.
JACC. Advances|June 28, 2024
Coronary Plaque in People With HIV vs Non-HIV Asymptomatic Community and Symptomatic Higher-Risk PopulationsJulia Karady, Michael T Lu, Göran Bergström, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
JACC. Cardiooncology|January 13, 2023
Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After ImmunotherapyCharlotte Lee, Zsofia D Drobni, Amna Zafar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2023
Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE CohortBorek Foldyna, Thomas Mayrhofer, Markella V Zanni, et al.
JACC. Cardiovascular Imaging|April 9, 2026
Opportunistic CT-Derived Periaortic Fat Attenuation as a Novel Marker of Mortality in Patients Undergoing TAVRJan M Brendel, Ibrahim Hadzic, Thomas Mayrhofer, et al.
Nature Communications|January 30, 2021
Deep convolutional neural networks to predict cardiovascular risk from computed tomographyRoman Zeleznik, Borek Foldyna, Parastou Eslami, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2022
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)Samuel R Schnittman, Michael T Lu, Thomas Mayrhofer, et al.
American Journal of Preventive Cardiology|May 20, 2024
Lipoprotein subclasses are associated with Hepatic steatosis: insights from the prospective multicenter imaging study for the evaluation of chest pain (PROMISE) clinical trialJulia Karady, Robert W McGarrah, Maggie Nguyen, et al.
JAMA Cardiology|December 11, 2024
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical TrialMárton Kolossváry, Samuel R Schnittman, Markella V Zanni, et al.
JAMA Network Open|June 29, 2021
Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular PreventionUdo Hoffmann, Michael T Lu, Borek Foldyna, et al.
JACC. Cardiovascular Imaging|December 1, 2025
Statin Effects on Pericoronary Adipose Tissue Density in People With HIV: Insights From the REPRIEVE TrialBorek Foldyna, Ibrahim Hadzic, Thomas Mayrhofer, et al.
JACC. Advances|June 28, 2024
Coronary Plaque in People With HIV vs Non-HIV Asymptomatic Community and Symptomatic Higher-Risk PopulationsJulia Karady, Michael T Lu, Göran Bergström, et al.
Pageof 10